RNA, 7SL, cytoplasmic 494, pseudogene (RN7SL494P)

RN7SL494P is a human pseudogene categorized as a noncoding RNA (7SL RNA pseudogene) and located on chromosome 15q21.2. While the parent molecule, 7SL RNA, serves as the RNA core of the signal recognition particle (SRP)—crucial for protein translocation across the endoplasmic reticulum membrane—RN7SL494P itself does not encode a functional SRP RNA. RN7SL494P is transcribed as a long noncoding RNA, but functional studies indicate that it lacks canonical biological roles in protein targeting or other cellular trafficking mechanisms. Genome-wide association and expression studies have revealed that RN7SL494P expression is correlated with patient survival in lung adenocarcinoma, especially with lymph node metastasis, supporting a possible role as a prognostic biomarker. There is currently no evidence that RN7SL494P acts as a therapeutic drug target; it is not classified as a receptor, enzyme, transporter, or established regulatory protein. Its biological activity is likely restricted to noncoding RNA functions, possibly by affecting expression networks or epigenetic landscapes, but there is no consensus that it performs a direct active function. Most 7SL pseudogenes, including RN7SL494P, are truncated, non-functional derivatives of 7SL RNA, produced by integration of reverse-transcribed RNA into the genome. RN7SL494P is a pseudogene, not a "classic" druggable target (enzyme, receptor, etc.); no current evidence for therapeutic intervention or small-molecule targeting associated with this locus. The parental 7SL RNA (from which the pseudogene derives) is a critical scaffold in SRP-mediated protein targeting, but RN7SL494P does not contribute this activity. Any biological associations are correlative and do not indicate a causal or actionable role for this pseudogene in disease mechanisms or drug discovery. RN7SL494P is not a therapeutic drug target, but may serve as a biomarker for prognosis in some cancers, notably lung adenocarcinoma. The gene is best categorized as a pseudogene and long noncoding RNA pseudogene with no canonical protein product and no direct disease mechanism or drug interactions identified. Functionally, RN7SL494P offers value to research primarily as a molecular marker rather than a biologically active therapeutic target.

Other names

RN7SL494PRNA, 7SL, cytoplasmic 494, pseudogene7SL pseudogene